Maximizing the potency of an anti-TLR4 monoclonal antibody by exploiting proximity to Fcγ receptors: Fc-mediated avidity enhances the potency of an anti-TLR4 antibody

In order to treat Toll like receptor 4 (TLR4)-mediated diseases, we generated a potent antagonistic antibody directed against human TLR4, Hu 15C1. This antibody's potency can be modulated by engaging not only TLR4 but also Fcγ receptors (FcγR), a mechanism that is driven by avidity and not cell...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:MAbs
Asıl Yazarlar: Loyau, Jérémy, Malinge, Pauline, Daubeuf, Bruno, Shang, Limin, Elson, Greg, Kosco-Vilbois, Marie, Fischer, Nicolas, Rousseau, François
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Taylor & Francis 2014
Konular:
Reports
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4622919/
https://ncbi.nlm.nih.gov/pubmed/25484053
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/19420862.2014.975098
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller